Viking Therapeutics, Inc. (VKTX)
Data as of , from SEC Form 4 filings.
See up to 3 months of VKTX. The 7-day demo opens the 1M and 3M ranges and puts VKTX on your watchlist.
Start 7-day demoLatest VKTX insider trades
About Viking Therapeutics, Inc. (VKTX)
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
- SAN DIEGO, CA
- 65
- 2015
- XNAS
https://www.vikingtherapeutics.comSEC filings for VKTX on EDGAR
VKTX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 3 | 187,951 | $6.27M |
| Grant or award | 5 | 332,134 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
VKTX insider transactions (Form 4)
9127 Form 4 filings on record, the earliest from Oct 25, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dorothy Elizabeth Kelly-Gemmell - Director | Grant or award | Common Stock, par value $0.00001 per share | 6,333 footnote F1 | $0.00 | - | |
| Dorothy Elizabeth Kelly-Gemmell - Director | Grant or award | Stock Option (Right to Buy) | 40,800 | $0.00 | - | |
| ||||||
| Brian Lian - Officer | Grant or award | Common Stock, par value $0.00001 per share | 221,667 footnote F1 | $0.00 | - | |
| Brian Lian - Officer | Open-market sale | Common Stock, par value $0.00001 per share | 148,517 footnote F2 | $33.32 footnote F3 | $4.95M | |
| ||||||
| Greg Zante - Officer | Grant or award | Common Stock, par value $0.00001 per share | 31,667 footnote F1 | $0.00 | - | |
| Greg Zante - Officer | Open-market sale | Common Stock, par value $0.00001 per share | 21,217 footnote F3 | $33.47 footnote F4 | $710K | |
| ||||||
| Marianna Mancini - Officer | Grant or award | Common Stock, par value $0.00001 per share | 31,667 footnote F1 | $0.00 | - | |
| Marianna Mancini - Officer | Open-market sale | Common Stock, par value $0.00001 per share | 18,217 footnote F3 | $33.47 footnote F4 | $610K | |
| ||||||
| Hubert C. Chen - Officer | Grant or award | Stock Option (Right to Buy) | 190,000 | $0.00 | - | |
| Neil William Aubuchon - Officer | Open-market purchase | Common Stock, par value $0.00001 per share | 4,475 | $33.50 | $150K | |
| Neil William Aubuchon - Officer | Grant or award | Stock Option (Right to Buy) | 180,000 | $0.00 | - | |
| Greg Zante - Officer | Grant or award | Common Stock, par value $0.00001 per share | 41,000 | $0.00 | - | |
| Greg Zante - Officer | Grant or award | Common Stock, par value $0.00001 per share | 32,049 | $0.00 | - | |
| Greg Zante - Officer | Open-market sale | Common Stock, par value $0.00001 per share | 31,961 | $32.30 | $1.03M | |
| Greg Zante - Officer | Open-market sale | Common Stock, par value $0.00001 per share | 13,900 | $33.38 | $464K | |
| Greg Zante - Officer | Open-market sale | Common Stock, par value $0.00001 per share | 10,300 | $34.24 | $353K | |
| Greg Zante - Officer | Open-market sale | Common Stock, par value $0.00001 per share | 1,500 | $32.09 | $48K | |
| Greg Zante - Officer | Grant or award | Stock Option (Right to Buy) | 91,000 | $0.00 | - | |
| Marianna Mancini - Officer | Grant or award | Common Stock, par value $0.00001 per share | 41,000 | $0.00 | - | |
| Marianna Mancini - Officer | Grant or award | Common Stock, par value $0.00001 per share | 32,049 | $0.00 | - | |
| Marianna Mancini - Officer | Open-market sale | Common Stock, par value $0.00001 per share | 31,961 | $32.29 | $1.03M | |
| Marianna Mancini - Officer | Open-market sale | Common Stock, par value $0.00001 per share | 13,600 | $33.37 | $454K | |
| Marianna Mancini - Officer | Open-market sale | Common Stock, par value $0.00001 per share | 10,500 | $34.22 | $359K | |
| Marianna Mancini - Officer | Open-market sale | Common Stock, par value $0.00001 per share | 1,600 | $35.07 | $56K | |
| Marianna Mancini - Officer | Grant or award | Stock Option (Right to Buy) | 91,000 | $0.00 | - | |
| Brian Lian - Officer | Grant or award | Common Stock, par value $0.00001 per share | 78,400 | $0.00 | - | |
| Brian Lian - Officer | Grant or award | Common Stock, par value $0.00001 per share | 224,080 | $0.00 | - | |
| Brian Lian - Officer | Open-market sale | Common Stock, par value $0.00001 per share | 132,454 | $32.29 | $4.28M | |
| Brian Lian - Officer | Open-market sale | Common Stock, par value $0.00001 per share | 53,279 | $33.38 | $1.78M | |
| Brian Lian - Officer | Open-market sale | Common Stock, par value $0.00001 per share | 41,276 | $34.22 | $1.41M | |
| Brian Lian - Officer | Open-market sale | Common Stock, par value $0.00001 per share | 6,400 | $35.07 | $224K | |
| Brian Lian - Officer | Grant or award | Stock Option (Right to Buy) | 176,300 | $0.00 | - | |
| J. Matthew Singleton | Grant or award | Common Stock, par value $0.00001 per share | 3,150 | $0.00 | - | |
| J. Matthew Singleton | Grant or award | Stock Option (Right to Buy) | 20,400 | $0.00 | - | |
| Lawson Macartney | Grant or award | Common Stock, par value $0.00001 per share | 3,150 | $0.00 | - | |
| Lawson Macartney | Grant or award | Stock Option (Right to Buy) | 20,400 | $0.00 | - | |
| Charles A. Rowland Jr. | Grant or award | Common Stock, par value $0.00001 per share | 3,150 | $0.00 | - | |
| Charles A. Rowland Jr. | Grant or award | Stock Option (Right to Buy) | 20,400 | $0.00 | - | |
| Matthew W. Foehr | Option exercise | Common Stock, par value $0.00001 per share | 16,000 | $3.33 | $53K | |
| Matthew W. Foehr | Open-market sale | Common Stock, par value $0.00001 per share | 16,000 | $35.11 | $562K | |
| Matthew W. Foehr | Grant or award | Common Stock, par value $0.00001 per share | 3,150 | $0.00 | - | |
| Matthew W. Foehr | Option exercise | Stock Option (Right to Buy) | 16,000 | $0.00 | - | |
| Matthew W. Foehr | Grant or award | Stock Option (Right to Buy) | 20,400 | $0.00 | - | |
| Sarah Kathryn Rouan | Grant or award | Common Stock, par value $0.00001 per share | 3,150 | $0.00 | - | |
| Sarah Kathryn Rouan | Grant or award | Stock Option (Right to Buy) | 20,400 | $0.00 | - | |
| Marianna Mancini - Officer | Open-market sale | Common Stock, par value $0.00001 per share | 6,185 footnote F2 | $35.00 footnote F3 | $216K | |
| Marianna Mancini - Officer | Grant or award | Common Stock, par value $0.00001 per share | 11,117 footnote F1 | $0.00 | - | |
| ||||||
| Brian Lian - Officer | Grant or award | Common Stock, par value $0.00001 per share | 70,084 footnote F1 | $0.00 | - | |
| Brian Lian - Officer | Open-market sale | Common Stock, par value $0.00001 per share | 38,989 footnote F2 | $35.01 footnote F3 | $1.36M | |
| ||||||
| Charles A. Rowland Jr. | Grant or award | Common Stock, par value $0.00001 per share | 16,000 | $4.48 | $72K | |
| Charles A. Rowland Jr. | Grant or award | Common Stock, par value $0.00001 per share | 22,000 | $5.80 | $128K | |
| Charles A. Rowland Jr. | Grant or award | Common Stock, par value $0.00001 per share | 22,000 | $4.88 | $107K | |
| Charles A. Rowland Jr. | Option exercise | Stock Option (Right to Buy) | 16,000 | $0.00 | - | |
| Charles A. Rowland Jr. | Option exercise | Stock Option (Right to Buy) | 22,000 | $0.00 | - | |
| Charles A. Rowland Jr. | Option exercise | Stock Option (Right to Buy) | 22,000 | $0.00 | - | |
| Charles A. Rowland Jr. | Open-market sale | Common Stock, par value $0.00001 per share | 60,000 | $35.57 footnote F1 | $2.13M | |
| ||||||
| Greg Zante - Officer | Grant or award | Common Stock, par value $0.00001 per share | 11,117 footnote F1 | $0.00 | - | |
| Greg Zante - Officer | Open-market sale | Common Stock, par value $0.00001 per share | 6,185 footnote F2 | $35.00 footnote F3 | $216K | |
| ||||||
| Brian Lian - Officer | Grant or award | Common Stock, par value $0.00001 per share | 48,333 | $0.00 | - | |
| Brian Lian - Officer | Open-market sale | Common Stock, par value $0.00001 per share | 26,889 | $27.80 | $748K | |
| Marianna Mancini - Officer | Grant or award | Common Stock, par value $0.00001 per share | 7,667 | $0.00 | - | |
| Marianna Mancini - Officer | Open-market sale | Common Stock, par value $0.00001 per share | 4,266 | $27.77 | $118K | |
| Greg Zante - Officer | Grant or award | Common Stock, par value $0.00001 per share | 7,667 | $0.00 | - | |
| Greg Zante - Officer | Open-market sale | Common Stock, par value $0.00001 per share | 4,266 | $27.76 | $118K | |
| Matthew W. Foehr | Option exercise | Common Stock, par value $0.00001 per share | 20,786 | $8.00 | $166K | |
| Matthew W. Foehr | Option exercise | Stock Option (Right to Buy) | 20,786 | $0.00 | - | |
| Lawson Macartney | Option exercise | Common Stock, par value $0.00001 per share | 2,000 | $5.80 | $12K | |
| Lawson Macartney | Open-market sale | Common Stock, par value $0.00001 per share | 2,000 | $68.67 | $137K | |
| Lawson Macartney | Option exercise | Stock Option (Right to Buy) | 2,000 | $0.00 | - | |
| Greg Zante - Officer | Option exercise | Common Stock, par value $0.00001 per share | 12,750 | $7.77 | $99K | |
| Greg Zante - Officer | Option exercise | Common Stock, par value $0.00001 per share | 4,251 | $4.68 | $20K | |
| Greg Zante - Officer | Option exercise | Common Stock, par value $0.00001 per share | 26,000 | $5.80 | $151K | |
| Greg Zante - Officer | Option exercise | Common Stock, par value $0.00001 per share | 51,000 | $8.52 | $435K | |
| Greg Zante - Officer | Open-market sale | Common Stock, par value $0.00001 per share | 49,672 | $74.56 | $3.70M | |
| Greg Zante - Officer | Open-market sale | Common Stock, par value $0.00001 per share | 18,620 | $75.79 | $1.41M | |
| Greg Zante - Officer | Open-market sale | Common Stock, par value $0.00001 per share | 9,265 | $76.94 | $713K | |
| Greg Zante - Officer | Open-market sale | Common Stock, par value $0.00001 per share | 23,082 | $77.68 | $1.79M | |
| Greg Zante - Officer | Open-market sale | Common Stock, par value $0.00001 per share | 15,825 | $78.69 | $1.25M | |
| Greg Zante - Officer | Open-market sale | Common Stock, par value $0.00001 per share | 6,050 | $79.78 | $483K | |
| Greg Zante - Officer | Open-market sale | Common Stock, par value $0.00001 per share | 7,967 | $80.65 | $643K | |
| Greg Zante - Officer | Open-market sale | Common Stock, par value $0.00001 per share | 1,206 | $81.44 | $98K | |
| Greg Zante - Officer | Option exercise | Stock Option (Right to Buy) | 12,750 | $0.00 | - | |
| Greg Zante - Officer | Option exercise | Stock Option (Right to Buy) | 4,251 | $0.00 | - | |
| Greg Zante - Officer | Option exercise | Stock Option (Right to Buy) | 26,000 | $0.00 | - | |
| Greg Zante - Officer | Option exercise | Stock Option (Right to Buy) | 51,000 | $0.00 | - | |
| Sarah Kathryn Rouan | Option exercise | Common Stock, par value $0.00001 per share | 11,000 | $4.88 | $54K | |
| Sarah Kathryn Rouan | Open-market sale | Common Stock, par value $0.00001 per share | 11,000 | $80.89 | $890K | |
| Sarah Kathryn Rouan | Option exercise | Stock Option (Right to Buy) | 11,000 | $0.00 | - | |
| J. Matthew Singleton | Option exercise | Common Stock, par value $0.00001 per share | 16,000 | $4.48 | $72K | |
| J. Matthew Singleton | Open-market sale | Common Stock, par value $0.00001 per share | 16,000 | $79.50 | $1.27M | |
| J. Matthew Singleton | Option exercise | Stock Option (Right to Buy) | 16,000 | $0.00 | - | |
Item 1.01, 2.03, 9.01
Item 8.01, 9.01
Item 2.02, 9.01
Item 5.07, 9.01
Recent VKTX Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - |
VKTX insider trading FAQ
What is the latest insider trade for VKTX?
Viking Therapeutics, Inc. (VKTX) had 4 insider filings in the last 90 days, with the most recent on 2026-08-07. The full record for VKTX runs to 27 Form 4 filings, the earliest from 2024-10-25. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying VKTX stock?
No insider purchases of VKTX were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling VKTX stock?
3 insider sales of VKTX were filed in the last 90 days, totaling $6.27M.
Where can I see VKTX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects VKTX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Dorothy Elizabeth Kelly-Gemmell view on EDGAR
- - Brian Lian view on EDGAR
- - Greg Zante view on EDGAR
- - Marianna Mancini view on EDGAR
- - Hubert C. Chen view on EDGAR
- - Neil William Aubuchon view on EDGAR
- - Neil William Aubuchon view on EDGAR
- - Greg Zante view on EDGAR
- - Marianna Mancini view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where VKTX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow VKTX with a 7-day demo
- VKTX on your watchlist
- Every VKTX Form 4 filing on record
- Up to 3 months of VKTX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
